Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Expert InterviewsAround the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Enhancing PNH Care: Collaborative Decision-Making and Improving Patient Experience : Episode 3

Navigating Treatment Options: Understanding Risks and Benefits

January 9, 2025
By David Dingli, MD, PhD
Brandi Lewis
Opinion
Video

Panelists discuss how to help patients weigh the risks and benefits of different treatment options for paroxysmal nocturnal hemoglobinuria (PNH), outlining tools and techniques used to ensure that patients and caregivers fully understand their choices and make informed decisions.

EP: 1.Recognizing PNH and Initial Challenges

EP: 2.Empowering Patients in Treatment Planning

Now Viewing

EP: 3.Navigating Treatment Options: Understanding Risks and Benefits

EP: 4.Decoding Symptoms: When Fatigue Speaks Volumes

EP: 5.Starting Treatment: Insights and Initial Experiences

EP: 6.Living With PNH: Long-Term Management and Caregiver Support

EP: 7.Patient Voices: Shaping the Future of PNH Care

EP: 8.Closing Reflection: A Journey of Understanding and Resilience

Video content above is prompted by the following:

  • How do you help patients weigh the risks and benefits of different treatment options?
  • What tools or techniques do you use to ensure patients and caregivers fully understand their choices?

This program was made possible with support from Novartis Pharmaceuticals.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content

Recap: Recent Advances in Multiple Myeloma From IMS 2022 and Beyond

Recap: Recent Advances in Multiple Myeloma From IMS 2022 and Beyond

ONCOLOGY Staff
September 12th 2025
Article

1 expert in this video

Prolaris in Practice: Guiding ADT Benefits, Clinical Application, and Expert Insights From ACRO 2025

Steven Finkelstein, MD, DABR, FACRO
September 12th 2025
Podcast

Recap: Recent Advances in the Treatment of Metastatic Castration-Sensitive Prostate Cancer

Recap: Recent Advances in the Treatment of Metastatic Castration-Sensitive Prostate Cancer

ONCOLOGY Staff
September 12th 2025
Article

1 expert in this video

CCR Scores and Beyond: Precision Strategies for Treatment Intensification in Prostate Cancer

Alvaro A. Martinez, MD
September 12th 2025
Podcast

Updates in Treatment of HER2-Positive Breast Cancer and Brain Metastases

Recap: Updates in Treatment of HER2-Positive Breast Cancer and Brain Metastases

ONCOLOGY Staff
September 12th 2025
Article

Recap: Emory Experts Review Treatment Strategies for Transplant-Ineligible Multiple Myeloma

Recap: Emory Experts Review Treatment Strategies for Transplant-Ineligible Multiple Myeloma

ONCOLOGY Staff
September 12th 2025
Article
Related Content

Recap: Recent Advances in Multiple Myeloma From IMS 2022 and Beyond

Recap: Recent Advances in Multiple Myeloma From IMS 2022 and Beyond

ONCOLOGY Staff
September 12th 2025
Article

1 expert in this video

Prolaris in Practice: Guiding ADT Benefits, Clinical Application, and Expert Insights From ACRO 2025

Steven Finkelstein, MD, DABR, FACRO
September 12th 2025
Podcast

Recap: Recent Advances in the Treatment of Metastatic Castration-Sensitive Prostate Cancer

Recap: Recent Advances in the Treatment of Metastatic Castration-Sensitive Prostate Cancer

ONCOLOGY Staff
September 12th 2025
Article

1 expert in this video

CCR Scores and Beyond: Precision Strategies for Treatment Intensification in Prostate Cancer

Alvaro A. Martinez, MD
September 12th 2025
Podcast

Updates in Treatment of HER2-Positive Breast Cancer and Brain Metastases

Recap: Updates in Treatment of HER2-Positive Breast Cancer and Brain Metastases

ONCOLOGY Staff
September 12th 2025
Article

Recap: Emory Experts Review Treatment Strategies for Transplant-Ineligible Multiple Myeloma

Recap: Emory Experts Review Treatment Strategies for Transplant-Ineligible Multiple Myeloma

ONCOLOGY Staff
September 12th 2025
Article
Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.